Related Experiment Video
Updated: Jul 16, 2026
07:40
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Emerging options with coxib therapy
1Department of Anesthesiology, State University of New York at Buffalo School of Medicine, USA. mlema@acsu.buffalo.edu
Cleveland Clinic Journal of Medicine
|June 28, 2002
Summary
Cyclooxygenase-2 selective inhibitors (coxibs) show potential beyond arthritis pain relief. Research is exploring their use in Alzheimer's disease treatment and colorectal cancer prevention, with promising preliminary results.
Area of Science:
- Pharmacology
- Oncology
- Neurology
Background:
- Cyclooxygenase-2 (COX-2) selective inhibitors (coxibs) are currently used for arthritis pain.
- Inflammatory mechanisms are implicated in Alzheimer's disease (AD) neurodegeneration.
- Coxibs are being investigated for chemopreventive benefits in colorectal cancer (CRC).
Purpose of the Study:
- To explore the extended clinical applications of coxibs.
- To evaluate the efficacy of coxibs in Alzheimer's disease.
- To assess the chemopreventive potential of coxibs in colorectal cancer.
Main Methods:
- Review of epidemiological surveys, preclinical studies, and clinical trials.
- Ongoing clinical trials investigating coxibs' effect on AD progression.
- Studies on tumor cell lines, animal, and human models for CRC chemoprevention.
Main Results:
- Preliminary evidence suggests a role for inflammatory mechanisms in AD.
- Coxibs demonstrate potential to promote apoptosis and inhibit angiogenesis in CRC.
- Coxibs offer an opioid-sparing effect in cancer pain management without significant adverse effects.
Conclusions:
- Coxibs may offer therapeutic benefits in Alzheimer's disease.
- Coxibs show promise as chemopreventive agents for colorectal cancer.
- Coxibs are valuable in palliative care for cancer pain management.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications